39 related articles for article (PubMed ID: 19924639)
1. Expression of OAT1 and OAT3 in differentiating proximal tubules of the mouse kidney.
Hwang JS; Park EY; Kim WY; Yang CW; Kim J
Histol Histopathol; 2010 Jan; 25(1):33-44. PubMed ID: 19924639
[TBL] [Abstract][Full Text] [Related]
2. Arsenic and Mercury Containing Traditional Chinese Medicine (Realgar and Cinnabar) Strongly Inhibit Organic Anion Transporters, Oat1 and Oat3, In Vivo in Mice.
Yu WH; Zhang N; Qi JF; Sun C; Wang YH; Lin M
Biomed Res Int; 2015; 2015():863971. PubMed ID: 26788513
[TBL] [Abstract][Full Text] [Related]
3. Renal Organic Anion Transporters 1 and 3 In Vitro: Gone but Not Forgotten.
Caetano-Pinto P; Stahl SH
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895098
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte nuclear factors 4α and 1α regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters.
Martovetsky G; Tee JB; Nigam SK
Mol Pharmacol; 2013 Dec; 84(6):808-23. PubMed ID: 24038112
[TBL] [Abstract][Full Text] [Related]
5. Profiling Cell Heterogeneity and Fructose Transporter Expression in the Rat Nephron by Integrating Single-Cell and Microdissected Tubule Segment Transcriptomes.
Zhang R; Jadhav DA; Kim N; Kramer B; Gonzalez-Vicente A;
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474316
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol metabolism of the renal proximal tubule S3 segment is disturbed in response to diabetes.
Rietjens RGJ; Wang G; van der Velden AIM; Koudijs A; Avramut MC; Kooijman S; Rensen PCN; van der Vlag J; Rabelink TJ; Heijs B; van den Berg BM
Sci Rep; 2023 Apr; 13(1):6261. PubMed ID: 37069341
[TBL] [Abstract][Full Text] [Related]
7. Profiling cellular heterogeneity and fructose transporter expression in the rat nephron by integrating single-cell and microdissected tubule segment transcriptomes.
Zhang R; Jadhav DA; Kramer B; Gonzalez-Vicente A;
bioRxiv; 2023 Dec; ():. PubMed ID: 38187558
[TBL] [Abstract][Full Text] [Related]
8. Development of a Highly Differentiated Human Primary Proximal Tubule MPS Model (aProximate MPS Flow).
Pisapia F; O'Brien D; Tasinato E; Garner KL; Brown CDA
Bioengineering (Basel); 2023 Dec; 11(1):. PubMed ID: 38275575
[TBL] [Abstract][Full Text] [Related]
9. Correction: Neamatallah et al. Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism.
Neamatallah T; El-Shitany N; Abbas A; Eid BG; Harakeh S; Ali S; Mousa S
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570904
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic renal transporters and cisplatin's toxicity in urinary bladder cancer patients: current perspectives and future directions.
Selim MS; Kassem AB; El-Bassiouny NA; Salahuddin A; Abu El-Ela RY; Hamza MS
Med Oncol; 2023 Jan; 40(2):80. PubMed ID: 36650399
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of Gyps africanus (African white-backed vulture) organic anion transporter 1 and 2 expressed in the kidney.
Nethathe B; Phaswane R; Abera A; Naidoo V
PLoS One; 2021; 16(5):e0250408. PubMed ID: 33945567
[TBL] [Abstract][Full Text] [Related]
12. Imputation of spatially-resolved transcriptomes by graph-regularized tensor completion.
Li Z; Song T; Yong J; Kuang R
PLoS Comput Biol; 2021 Apr; 17(4):e1008218. PubMed ID: 33826608
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of Hydrochlorothiazide in Children: A Potential Surrogate for Renal Secretion Maturation.
Commander SJ; Wu H; Boakye-Agyeman F; Melloni C; Hornik CD; Zimmerman K; Al-Uzri A; Mendley SR; Harper B; Cohen-Wolkowiez M; Hornik CP;
J Clin Pharmacol; 2021 Mar; 61(3):368-377. PubMed ID: 33029806
[TBL] [Abstract][Full Text] [Related]
14. Generation and Characterisation of a Pax8-CreERT2 Transgenic Line and a Slc22a6-CreERT2 Knock-In Line for Inducible and Specific Genetic Manipulation of Renal Tubular Epithelial Cells.
Espana-Agusti J; Zou X; Wong K; Fu B; Yang F; Tuveson DA; Adams DJ; Matakidou A
PLoS One; 2016; 11(2):e0148055. PubMed ID: 26866916
[TBL] [Abstract][Full Text] [Related]
15. The organic anion transporter (OAT) family: a systems biology perspective.
Nigam SK; Bush KT; Martovetsky G; Ahn SY; Liu HC; Richard E; Bhatnagar V; Wu W
Physiol Rev; 2015 Jan; 95(1):83-123. PubMed ID: 25540139
[TBL] [Abstract][Full Text] [Related]
16. Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways.
Wu W; Jamshidi N; Eraly SA; Liu HC; Bush KT; Palsson BO; Nigam SK
Drug Metab Dispos; 2013 Oct; 41(10):1825-34. PubMed ID: 23920220
[TBL] [Abstract][Full Text] [Related]
17. Sex-dependent expression of Oat3 (Slc22a8) and Oat1 (Slc22a6) proteins in murine kidneys.
Breljak D; Brzica H; Sweet DH; Anzai N; Sabolic I
Am J Physiol Renal Physiol; 2013 Apr; 304(8):F1114-26. PubMed ID: 23389457
[TBL] [Abstract][Full Text] [Related]
18. Organic anion and cation SLC22 "drug" transporter (Oat1, Oat3, and Oct1) regulation during development and maturation of the kidney proximal tubule.
Gallegos TF; Martovetsky G; Kouznetsova V; Bush KT; Nigam SK
PLoS One; 2012; 7(7):e40796. PubMed ID: 22808265
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical studies of organic anion transporters and urate transporter 1 expression in human salivary gland.
Ikarashi R; Shibasaki K; Yamaguchi A
Acta Odontol Scand; 2013 Mar; 71(2):312-6. PubMed ID: 22564045
[TBL] [Abstract][Full Text] [Related]
20. Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney.
Sweeney DE; Vallon V; Rieg T; Wu W; Gallegos TF; Nigam SK
Mol Pharmacol; 2011 Jul; 80(1):147-54. PubMed ID: 21493727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
